BUZZ-IntelliPharmaCeutics International Inc: Pain drug gets "fast track" status

Tue May 26, 2015 8:33am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Canadian biotech company's U.S.-listed shares up 21 pct at $3.75 premarket

** Company said U.S. FDA granted its abuse-deterrent pain drug "fast track" status

** Fast track status expedites review of drugs intended to treat serious conditions that have few or no treatment options

** Drug, Rexista Oxycodone XR, is intended for management of pain when an around-the-clock analgesic is needed for extended period of time

** Up to Friday's close, stock had risen about 37 pct this year